Treatment of severe refractory erythema nodosum leprosum with tumor necrosis factor inhibitor Etanercept

被引：12
|
作者：
Chowdhry, Sundeep [1 ]
Shukla, Akhilesh [1 ]
D'souza, Paschal [1 ]
Dhali, Tapan [1 ]
Jaiswal, Prashansa [1 ]
机构：
[1] ESI Postgrad Inst Med Sci & Res, Dept Dermatol Venereol & Leprol, New Delhi 110015, India
来源：
INTERNATIONAL JOURNAL OF MYCOBACTERIOLOGY | 2016年 / 5卷 / 02期
关键词：
Biologics; Etanercept; Erythema nodosum leprosum; Leprosy; Treatment;
D O I：
10.1016/j.ijmyco.2016.02.002
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
Erythema nodosum leprosum (ENL) is a common complication of lepromatous leprosy. Some patients unresponsive to conventional, first-line therapeutics develop recurrent, recalcitrant ENL. Here, we report a case of severe refractory ENL that was successfully treated with Etanercept. Biologics may be considered as therapeutic alternatives in management of severe, recalcitrant ENL. (C) 2016 Asian-African Society for Mycobacteriology. Production and hosting by Elsevier Ltd. All rights reserved.
引用
收藏
页码：223 / 225
页数：3
相关论文
共 50 条
  • [21] Chemotherapy-induced erythema nodosum leprosum: successful treatment with thalidomide
    Petering, H
    Kiehl, P
    Vogelbruch, M
    Sticht-Groh, V
    Kapp, A
    Werfel, T
    HAUTARZT, 2001, 52 : 966 - 969
  • [22] INVITRO TUMOR-NECROSIS-FACTOR PRODUCTION BY MONONUCLEAR-CELLS FROM LEPROMATOUS LEPROSY PATIENTS AND FROM PATIENTS WITH ERYTHEMA-NODOSUM LEPROSUM
    SANTOS, DO
    SUFFYS, PN
    BONIFACIO, K
    MARQUES, MA
    SARNO, EN
    CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1993, 67 (03): : 199 - 203
  • [23] Listeria Rhomboencephalitis in a Patient on a Tumor Necrosis Factor a Inhibitor (Etanercept)
    Mathews, Benji K.
    Chuang, Charles
    Rawal, Ajay
    Gertner, Elie
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2014, 20 (06) : 325 - 327
  • [24] Tuberculosis following the use of etanercept, a tumor necrosis factor inhibitor
    Mohan, AK
    Coté, TR
    Block, JA
    Manadan, AM
    Siegel, JN
    Braun, MM
    CLINICAL INFECTIOUS DISEASES, 2004, 39 (03) : 295 - 299
  • [25] Our experience of the use of thalidomide in the steroid-dependent severe erythema nodosum leprosum
    Chaudhry, Nidhi S.
    Rath, Swapnil R.
    Visvanath, Vishalakshi
    Torsekar, R. G.
    INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2009, 75 (02): : 189 - 190
  • [26] Necrotic erythema nodosum leprosum - A case of severe lepromatous reaction in a multibacillary leprosy patient
    Nagarajan, Hrithik Dakssesh Putta
    Kamaraj, Balakrishnan
    Selvanathan, Keerthivasan
    Kumar, Shubham
    Gaidhane, Shilpa
    Sah, Sanjit
    Satapathy, Prakasini
    Mehta, Rachana
    Ndabashinze, Rodrigue
    Verma, Amogh
    IDCASES, 2025, 39
  • [27] POSSIBLE INCOMPATIBILITY OF DAPSONE WITH CLOFAZIMINE IN THE TREATMENT OF PATIENTS WITH ERYTHEMA-NODOSUM LEPROSUM
    IMKAMP, FMJH
    ANDERSON, R
    GATNER, EMS
    LEPROSY REVIEW, 1982, 53 (02) : 148 - 149
  • [28] The Effects of Prednisolone Treatment on Cytokine Expression in Patients with Erythema Nodosum Leprosum Reactions
    Negera, Edessa
    Walker, Stephen L.
    Bobosha, Kidist
    Bekele, Yonas
    Endale, Birtukan
    Tarekegn, Azeb
    Abebe, Markos
    Aseffa, Abraham
    Dockrell, Hazel M.
    Lockwood, Diana N.
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [29] Beneficial Effect of Minocycline as Additional Treatment to Prednisone for Pustular Erythema Nodosum Leprosum
    Gunawan, Hendra
    Faldian, Yogi
    Hindritiani, Reti
    INTERNATIONAL MEDICAL CASE REPORTS JOURNAL, 2022, 15 : 263 - 268
  • [30] Serum macrophage migration inhibitory factor levels in leprosy patients with erythema nodosum leprosum
    Bansal, Frainey
    Narang, Tarun
    Dogra, Sunil
    Vinay, Keshavamurthy
    Chhabra, Seema
    INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2018, 84 (05): : 573 - 577
12345